Demant Past Earnings Performance
Past criteria checks 2/6
Demant has been growing earnings at an average annual rate of 15.5%, while the Medical Equipment industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 10.9% per year. Demant's return on equity is 26.7%, and it has net margins of 11.1%.
Key information
15.5%
Earnings growth rate
17.6%
EPS growth rate
| Medical Equipment Industry Growth | -1.7% |
| Revenue growth rate | 10.9% |
| Return on equity | 26.7% |
| Net Margin | 11.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Demant (CPH:DEMANT) Is Reinvesting At Lower Rates Of Return
Nov 05
When Should You Buy Demant A/S (CPH:DEMANT)?
Oct 23Why Investors Shouldn't Be Surprised By Demant A/S' (CPH:DEMANT) P/E
Oct 09Is There An Opportunity With Demant A/S' (CPH:DEMANT) 42% Undervaluation?
Sep 12Is Demant (CPH:DEMANT) Using Too Much Debt?
Aug 30Demant (CPH:DEMANT) May Have Issues Allocating Its Capital
Jul 14Here's Why We Think Demant (CPH:DEMANT) Might Deserve Your Attention Today
Jun 30At kr.326, Is It Time To Put Demant A/S (CPH:DEMANT) On Your Watch List?
Jun 16Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 97% Above Its Share Price
Jun 03We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt
May 22Investors Still Waiting For A Pull Back In Demant A/S (CPH:DEMANT)
Apr 26Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Mar 18Capital Allocation Trends At Demant (CPH:DEMANT) Aren't Ideal
Mar 06Here's Why We Think Demant (CPH:DEMANT) Is Well Worth Watching
Feb 22Demant (CPH:DEMANT) Has A Pretty Healthy Balance Sheet
Feb 08Demant A/S (CPH:DEMANT) Not Flying Under The Radar
Jan 22A Look At The Fair Value Of Demant A/S (CPH:DEMANT)
Jan 04At kr.302, Is Demant A/S (CPH:DEMANT) Worth Looking At Closely?
Dec 17Some Investors May Be Worried About Demant's (CPH:DEMANT) Returns On Capital
Oct 31Is Demant (CPH:DEMANT) Using Too Much Debt?
Oct 16Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 34% Above Its Share Price
Oct 01Here's What's Concerning About Demant's (CPH:DEMANT) Returns On Capital
Jul 26Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Jul 11A Look At The Fair Value Of Demant A/S (CPH:DEMANT)
Jun 26Here's Why Demant (CPH:DEMANT) Can Manage Its Debt Responsibly
Jun 13Demant (CPH:DEMANT) May Have Issues Allocating Its Capital
Apr 18Is It Too Late To Consider Buying Demant A/S (CPH:DEMANT)?
Apr 04Are Investors Undervaluing Demant A/S (CPH:DEMANT) By 25%?
Mar 21These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Reasonably Well
Mar 08Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 77% Above Its Share Price
Dec 06Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future
Nov 22We Think Demant (CPH:DEMANT) Can Stay On Top Of Its Debt
Oct 04Does Demant (CPH:DEMANT) Deserve A Spot On Your Watchlist?
Sep 20Demant A/S' (CPH:DEMANT) Intrinsic Value Is Potentially 95% Above Its Share Price
Sep 07What Is Demant A/S's (CPH:DEMANT) Share Price Doing?
Aug 19Many Would Be Envious Of Demant's (CPH:DEMANT) Excellent Returns On Capital
Jul 18Demant (CPH:DEMANT) Seems To Use Debt Rather Sparingly
Jun 22Demant A/S (CPH:DEMANT) Shares Could Be 42% Below Their Intrinsic Value Estimate
Jun 09If You Like EPS Growth Then Check Out Demant (CPH:DEMANT) Before It's Too Late
May 28Is Now The Time To Look At Buying Demant A/S (CPH:DEMANT)?
May 16Shareholders Are Optimistic That Demant (CPH:DEMANT) Will Multiply In Value
Apr 09Is Demant (CPH:DEMANT) A Risky Investment?
Mar 16Shareholders Would Not Be Objecting To Demant A/S' (CPH:DEMANT) CEO Compensation And Here's Why
Mar 03Is There An Opportunity With Demant A/S' (CPH:DEMANT) 23% Undervaluation?
Mar 01Should You Be Adding Demant (CPH:DEMANT) To Your Watchlist Today?
Feb 17What Does Demant A/S's (CPH:DEMANT) Share Price Indicate?
Feb 05Capital Investment Trends At Demant (CPH:DEMANT) Look Strong
Jan 05Does Demant (CPH:DEMANT) Have A Healthy Balance Sheet?
Dec 08Estimating The Fair Value Of Demant A/S (CPH:DEMANT)
Nov 13Is Now An Opportune Moment To Examine Demant A/S (CPH:DEMANT)?
Oct 31Capital Investments At Demant (CPH:DEMANT) Point To A Promising Future
Oct 04These 4 Measures Indicate That Demant (CPH:DEMANT) Is Using Debt Safely
Sep 08Is It Time To Consider Buying Demant A/S (CPH:DEMANT)?
Jul 26Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Demant makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 22,836 | 2,535 | 11,490 | 1,536 |
| 31 Mar 24 | 22,640 | 2,544 | 11,263 | 1,473 |
| 31 Dec 23 | 22,443 | 2,552 | 11,036 | 1,410 |
| 30 Sep 23 | 21,442 | 2,577 | 10,732 | 1,291 |
| 30 Jun 23 | 20,902 | 2,488 | 10,633 | 1,270 |
| 31 Mar 23 | 20,304 | 2,381 | 10,440 | 1,292 |
| 31 Dec 22 | 19,705 | 2,274 | 10,246 | 1,314 |
| 30 Sep 22 | 19,181 | 2,460 | 9,851 | 1,274 |
| 30 Jun 22 | 18,656 | 2,645 | 9,455 | 1,233 |
| 31 Mar 22 | 18,281 | 2,671 | 9,178 | 1,186 |
| 31 Dec 21 | 17,905 | 2,696 | 8,900 | 1,139 |
| 30 Sep 21 | 17,521 | 2,453 | 8,651 | 1,170 |
| 30 Jun 21 | 17,137 | 2,209 | 8,401 | 1,200 |
| 31 Mar 21 | 15,803 | 1,665 | 8,145 | 1,231 |
| 31 Dec 20 | 14,469 | 1,121 | 7,889 | 1,261 |
| 30 Sep 20 | 14,072 | 970 | 7,952 | 1,224 |
| 30 Jun 20 | 13,674 | 818 | 8,014 | 1,186 |
| 31 Mar 20 | 14,310 | 1,140 | 8,138 | 1,153 |
| 31 Dec 19 | 14,946 | 1,462 | 8,261 | 1,120 |
| 30 Sep 19 | 14,728 | 1,579 | 8,068 | 1,093 |
| 30 Jun 19 | 14,510 | 1,695 | 7,874 | 1,066 |
| 31 Mar 19 | 14,224 | 1,759 | 7,593 | 1,030 |
| 31 Dec 18 | 13,937 | 1,823 | 7,312 | 994 |
| 30 Sep 18 | 13,699 | 1,836 | 7,084 | 956 |
| 30 Jun 18 | 13,461 | 1,849 | 6,856 | 918 |
| 31 Mar 18 | 13,325 | 1,802 | 6,809 | 887 |
| 31 Dec 17 | 13,189 | 1,754 | 6,762 | 856 |
| 30 Sep 17 | 12,943 | 1,689 | 6,680 | 831 |
| 30 Jun 17 | 12,697 | 1,624 | 6,597 | 806 |
| 31 Mar 17 | 12,350 | 1,542 | 6,436 | 795 |
| 31 Dec 16 | 12,002 | 1,459 | 6,275 | 784 |
| 30 Sep 16 | 11,717 | 1,429 | 6,068 | 787 |
| 30 Jun 16 | 11,432 | 1,399 | 5,860 | 790 |
| 31 Mar 16 | 11,049 | 1,418 | 5,573 | 777 |
| 31 Dec 15 | 10,665 | 1,436 | 5,285 | 763 |
| 30 Sep 15 | 10,258 | 1,402 | 5,090 | 731 |
| 30 Jun 15 | 9,850 | 1,367 | 4,894 | 699 |
| 31 Mar 15 | 9,598 | 1,347 | 4,693 | 690 |
| 31 Dec 14 | 9,346 | 1,326 | 4,491 | 680 |
| 30 Sep 14 | 9,221 | 1,301 | 4,420 | 673 |
| 30 Jun 14 | 9,095 | 1,275 | 4,348 | 665 |
| 31 Mar 14 | 9,027 | 1,280 | 4,294 | 650 |
| 31 Dec 13 | 8,959 | 1,285 | 4,239 | 634 |
Quality Earnings: DEMANT has high quality earnings.
Growing Profit Margin: DEMANT's current net profit margins (11.1%) are lower than last year (11.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DEMANT's earnings have grown by 15.5% per year over the past 5 years.
Accelerating Growth: DEMANT's earnings growth over the past year (1.9%) is below its 5-year average (15.5% per year).
Earnings vs Industry: DEMANT earnings growth over the past year (1.9%) did not outperform the Medical Equipment industry 13%.
Return on Equity
High ROE: Whilst DEMANT's Return on Equity (26.65%) is high, this metric is skewed due to their high level of debt.